Question
How de novo pyrimidine nucleotide biosynthesis is regulated?
Answer :
Word Count : 490
De novo pyrimidine nucleotide biosynthesis is tightly regulated to maintain balanced nucleotide pools required for DNA replication, RNA synthesis, and cellular growth. Regulation mainly occurs at the early committed steps of the pathway through feedback inhibition, feed-forward activation, allosteric modulation, covalent modification, and coordination with cellular growth signals and cell cycle status. The overall goal of regulation is to match pyrimidine production with cellular demand and prevent wasteful overproduction. The most important regulatory step in eukaryotes occurs at carbamoyl phosphate synthetase II (CPS II), which catalyzes the first committed reaction of pyrimidine synthesis and is considered the rate-limiting enzyme. CPS II is strongly inhibited by UTP, an end product of the pathway, representing classical feedback inhibition. When intracellular UTP levels rise, CPS ____ ________ ________ ________ ____ ___ _______ ____ __________.
___ ____ _____ _________ _______.
_________ ________ ___ ____ ______ ________ ______ ______.
__________ _____ _____ ___ _____ _______ _____ _____ ___ ___ _______.
______ ____ _____ __________ _____ __________ _______ ____ _____ _________ _____ ___.
________ ________ ______ ___ __________.
_______ ______ _____ _______ ____ ___.
_________ ___ ____ ______ ________ __________ ________ _________ ________ ____ _________ _______.
__________ _____ ___ ________ __________ ________ ________ ___.
________ _________ _____ _____ __________ ___ _________ _______ _______ ______ ___ ______.
______ ___ _______ _________ _____ ___ ______ _______.
______ ________ ____ __________ ______ ___ _________ _________ ____ _________ ____.
__________ __________ ___ ____ __________ __________ __________ ________ ___ ______.
________ ________ __________ _____ ___ _______ ______ _______ _________ _________ ______.
__________ ____ ________ __________ __________ ________ __________ ___ ________ __________ __________.
____ __________ __________ __________ _______ ______.
_______ _______ _____ ____ _____ _____ ________ ______ _____ ____.
_____ _________ _____ __________ ________ ________ ________.
_________ _______ _________ ________ _________ ___ _______ _____.
____ __________ __________ ___ ____ ______ ___ ____ ______ _________ ______ ___.
_____ ______ ___ _____ ____ ____ ______.
_______ ____ ________ ______ ____ ____ ____ ___ _____.
____ _____ _____ _______ ______ __________ ________.
__________ ___ _____ __________ ________ ______ _______ ______ _______.
___ _____ _______ ___ _____ __________ _____ _________ ___ ________ _________.
__________ _________ ________ _________ __________ ______ ____ _____ _____ __________ _________ _______.
______ ________ ____ _______ ___ ____ __________ ___ __________ ___ ____.
_________ __________ ________ ___ _____ __________.
_____ ______ ____ ____ _________ _____ __________ ____ ____ ___.
___ _____ _________ _______ __________ ___.
___ _____ ____ ____ ______ _______ ________ _________ ____ ________ _____ ___.
_______ ________ ___ _______ _______ ____ ______ ___ _____.
_________ ____ ___ _______ ___ ___ _________ ___.
_______ _________ ______ ____ ___ __________ _____ __________ __________ ______ ________.
____ ___ _____ ____ __________ _________ _________ __________ _________ _____ _____.
_________ ___ ________ ____ ___ ____ ___.
_____ ________ _______ ________ ________.
_____ __________ ________ _________ _______ _________ ____ ______ ____ ______ ___.
_____ _____ ________ _________ __________ _____ __________ ______ __________.
______ ________ ___ ___ ___ ______ ______ ____ __________ ________ __________.
________ _______ _______ ________.
Get Full Answer on WhatsApp
De novo pyrimidine nucleotide biosynthesis is tightly regulated to maintain balanced nucleotide pools required for DNA replication, RNA synthesis, and cellular growth. Regulation mainly occurs at the early committed steps of the pathway through feedback inhibition, feed-forward activation, allosteric modulation, covalent modification, and coordination with cellular growth signals and cell cycle status. The overall goal of regulation is to match pyrimidine production with cellular demand and prevent wasteful overproduction. The most important regulatory step in eukaryotes occurs at carbamoyl phosphate synthetase II (CPS II), which catalyzes the first committed reaction of pyrimidine synthesis and is considered the rate-limiting enzyme. CPS II is strongly inhibited by UTP, an end product of the pathway, representing classical feedback inhibition. When intracellular UTP levels rise, CPS ____ ________ ________ ________ ____ ___ _______ ____ __________.
___ ____ _____ _________ _______.
_________ ________ ___ ____ ______ ________ ______ ______.
__________ _____ _____ ___ _____ _______ _____ _____ ___ ___ _______.
______ ____ _____ __________ _____ __________ _______ ____ _____ _________ _____ ___.
________ ________ ______ ___ __________.
_______ ______ _____ _______ ____ ___.
_________ ___ ____ ______ ________ __________ ________ _________ ________ ____ _________ _______.
__________ _____ ___ ________ __________ ________ ________ ___.
________ _________ _____ _____ __________ ___ _________ _______ _______ ______ ___ ______.
______ ___ _______ _________ _____ ___ ______ _______.
______ ________ ____ __________ ______ ___ _________ _________ ____ _________ ____.
__________ __________ ___ ____ __________ __________ __________ ________ ___ ______.
________ ________ __________ _____ ___ _______ ______ _______ _________ _________ ______.
__________ ____ ________ __________ __________ ________ __________ ___ ________ __________ __________.
____ __________ __________ __________ _______ ______.
_______ _______ _____ ____ _____ _____ ________ ______ _____ ____.
_____ _________ _____ __________ ________ ________ ________.
_________ _______ _________ ________ _________ ___ _______ _____.
____ __________ __________ ___ ____ ______ ___ ____ ______ _________ ______ ___.
_____ ______ ___ _____ ____ ____ ______.
_______ ____ ________ ______ ____ ____ ____ ___ _____.
____ _____ _____ _______ ______ __________ ________.
__________ ___ _____ __________ ________ ______ _______ ______ _______.
___ _____ _______ ___ _____ __________ _____ _________ ___ ________ _________.
__________ _________ ________ _________ __________ ______ ____ _____ _____ __________ _________ _______.
______ ________ ____ _______ ___ ____ __________ ___ __________ ___ ____.
_________ __________ ________ ___ _____ __________.
_____ ______ ____ ____ _________ _____ __________ ____ ____ ___.
___ _____ _________ _______ __________ ___.
___ _____ ____ ____ ______ _______ ________ _________ ____ ________ _____ ___.
_______ ________ ___ _______ _______ ____ ______ ___ _____.
_________ ____ ___ _______ ___ ___ _________ ___.
_______ _________ ______ ____ ___ __________ _____ __________ __________ ______ ________.
____ ___ _____ ____ __________ _________ _________ __________ _________ _____ _____.
_________ ___ ________ ____ ___ ____ ___.
_____ ________ _______ ________ ________.
_____ __________ ________ _________ _______ _________ ____ ______ ____ ______ ___.
_____ _____ ________ _________ __________ _____ __________ ______ __________.
______ ________ ___ ___ ___ ______ ______ ____ __________ ________ __________.
________ _______ _______ ________.
Get Full Answer on WhatsApp
IGNOU NEWS
Assignment Submission Last Date Extended Till 30 June 2026 Click Here★★★IGNOU June 2026 TEE Date Sheet Released Click Here★★★